nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—nerve—hypothyroidism	0.0981	0.264	CbGeAlD
Vapreotide—SSTR5—pituitary gland—hypothyroidism	0.071	0.191	CbGeAlD
Vapreotide—SSTR5—cerebellum—hypothyroidism	0.0485	0.13	CbGeAlD
Vapreotide—SSTR2—pituitary gland—hypothyroidism	0.0458	0.123	CbGeAlD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0342	0.0544	CbGpPWpGaD
Vapreotide—SSTR2—cerebellum—hypothyroidism	0.0312	0.0841	CbGeAlD
Vapreotide—SSTR5—Peptide GPCRs—TSHR—hypothyroidism	0.0293	0.0466	CbGpPWpGaD
Vapreotide—TACR1—adrenal gland—hypothyroidism	0.0272	0.0732	CbGeAlD
Vapreotide—TACR1—blood—hypothyroidism	0.0272	0.0731	CbGeAlD
Vapreotide—SSTR2—Peptide GPCRs—TSHR—hypothyroidism	0.027	0.043	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0269	0.0428	CbGpPWpGaD
Vapreotide—TACR1—testis—hypothyroidism	0.0225	0.0605	CbGeAlD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.022	0.035	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—TSHR—hypothyroidism	0.0213	0.0338	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.0173	0.0276	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—TRH—hypothyroidism	0.0155	0.0246	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—TRH—hypothyroidism	0.0143	0.0227	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—TRH—hypothyroidism	0.0114	0.0181	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.0112	0.0179	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.0104	0.0165	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.0102	0.0162	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00956	0.0152	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00924	0.0147	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00924	0.0147	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00877	0.014	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00852	0.0136	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00852	0.0136	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00812	0.0129	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—TRH—hypothyroidism	0.00789	0.0126	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00753	0.012	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00749	0.0119	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—TRH—hypothyroidism	0.00728	0.0116	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—TSHB—hypothyroidism	0.00703	0.0112	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—TSHR—hypothyroidism	0.00703	0.0112	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.0069	0.011	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00671	0.0107	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00671	0.0107	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—TSHB—hypothyroidism	0.00649	0.0103	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—TSHR—hypothyroidism	0.00649	0.0103	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—AVP—hypothyroidism	0.00597	0.0095	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.0059	0.00938	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—TRH—hypothyroidism	0.00573	0.00912	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00544	0.00866	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00539	0.00858	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00534	0.0085	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—TSHB—hypothyroidism	0.00511	0.00813	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—TSHR—hypothyroidism	0.00511	0.00813	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00502	0.00799	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00498	0.00792	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—POMC—hypothyroidism	0.00455	0.00724	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—TRH—hypothyroidism	0.00446	0.0071	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—POMC—hypothyroidism	0.0042	0.00668	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—AVP—hypothyroidism	0.00415	0.0066	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—TRH—hypothyroidism	0.00412	0.00655	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TRH—hypothyroidism	0.00405	0.00644	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—TSHB—hypothyroidism	0.00398	0.00632	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—TSHR—hypothyroidism	0.00398	0.00632	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00396	0.00629	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00392	0.00623	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—AVP—hypothyroidism	0.00383	0.00609	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TRH—hypothyroidism	0.00374	0.00595	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—TSHB—hypothyroidism	0.00367	0.00584	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—TSHR—hypothyroidism	0.00367	0.00584	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00362	0.00576	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TSHB—hypothyroidism	0.00361	0.00574	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TSHR—hypothyroidism	0.00361	0.00574	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00334	0.00531	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TSHB—hypothyroidism	0.00333	0.0053	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TSHR—hypothyroidism	0.00333	0.0053	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—TRH—hypothyroidism	0.00324	0.00516	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—AVP—hypothyroidism	0.00301	0.00479	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TRH—hypothyroidism	0.00294	0.00468	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—TSHB—hypothyroidism	0.00289	0.00459	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—TSHR—hypothyroidism	0.00289	0.00459	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CLTC—hypothyroidism	0.00277	0.0044	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—POMC—hypothyroidism	0.00276	0.00438	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00263	0.00418	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TSHB—hypothyroidism	0.00262	0.00417	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TSHR—hypothyroidism	0.00262	0.00417	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CLTC—hypothyroidism	0.00255	0.00406	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—POMC—hypothyroidism	0.00254	0.00404	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—VAV3—hypothyroidism	0.00243	0.00387	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TRH—hypothyroidism	0.00239	0.00381	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AVP—hypothyroidism	0.00234	0.00373	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—VAV3—hypothyroidism	0.00224	0.00357	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—VAV3—hypothyroidism	0.00221	0.00351	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TRH—hypothyroidism	0.00221	0.00351	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AVP—hypothyroidism	0.00216	0.00344	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TSHB—hypothyroidism	0.00213	0.00339	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TSHR—hypothyroidism	0.00213	0.00339	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AVP—hypothyroidism	0.00213	0.00338	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—VAV3—hypothyroidism	0.00204	0.00324	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CLTC—hypothyroidism	0.00201	0.0032	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—POMC—hypothyroidism	0.002	0.00318	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TSHR—hypothyroidism	0.00197	0.00313	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TSHB—hypothyroidism	0.00197	0.00313	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AVP—hypothyroidism	0.00196	0.00312	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SH2B3—hypothyroidism	0.0019	0.00302	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—VAV3—hypothyroidism	0.00177	0.00281	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SH2B3—hypothyroidism	0.00175	0.00279	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TRH—hypothyroidism	0.00174	0.00277	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AVP—hypothyroidism	0.0017	0.00271	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—VAV3—hypothyroidism	0.0016	0.00255	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—POMC—hypothyroidism	0.00156	0.00248	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TSHR—hypothyroidism	0.00155	0.00246	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TSHB—hypothyroidism	0.00155	0.00246	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AVP—hypothyroidism	0.00155	0.00246	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—POMC—hypothyroidism	0.00144	0.00229	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—POMC—hypothyroidism	0.00141	0.00225	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRL—hypothyroidism	0.00141	0.00224	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SH2B3—hypothyroidism	0.00138	0.0022	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—POMC—hypothyroidism	0.0013	0.00208	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VAV3—hypothyroidism	0.0013	0.00208	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRL—hypothyroidism	0.0013	0.00207	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AVP—hypothyroidism	0.00126	0.002	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VAV3—hypothyroidism	0.0012	0.00192	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AVP—hypothyroidism	0.00116	0.00185	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—POMC—hypothyroidism	0.00113	0.0018	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—POMC—hypothyroidism	0.00103	0.00163	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRL—hypothyroidism	0.00102	0.00163	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VAV3—hypothyroidism	0.000948	0.00151	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AVP—hypothyroidism	0.000913	0.00145	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—POMC—hypothyroidism	0.000835	0.00133	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1—hypothyroidism	0.000803	0.00128	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—POMC—hypothyroidism	0.000771	0.00123	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1—hypothyroidism	0.000741	0.00118	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—POMC—hypothyroidism	0.000607	0.000965	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1—hypothyroidism	0.000584	0.000929	CbGpPWpGaD
